Narrow band imaging for the detection of gastric intestinal metaplasia and dysplasia during surveillance endoscopy.
Background Surveillance of premalignant gastric lesions relies mainly on random biopsy sampling. Narrow band imaging (NBI) may enhance the accuracy of endoscopic surveillance of intestinal metaplasia (IM) and dysplasia.We aimed to compare the yield of NBI to white light endoscopy (WLE) in the surveillance of patients with (IMa)and dysplasia.Methods Patients with previously identified gastric IM or dysplasia underwent a surveillance endoscopy. Both WLE and NBI were performed in all patients during a single procedure. The sensitivity of WLE and NBI for the detection of premalignant lesions was calculated by correlating endoscopic findings to histological diagnosis.Results Forty-three patients (28 males and 15 females,mean age 59 years) were included. IM was diagnosed in 27 patients; 20 were detected by NBI and WLE, four solely by NBI and three by random biopsies only. Dysplasia was detected in seven patients by WLE and NBI and in two patients by random biopsies only. Sixty-eight endoscopically detected lesions contained IM: 47 were detected by WLE and NBI, 21 by NBI only. Nine endoscopically detected lesions demonstrated dysplasia: eight were detected by WLE and NBI, one was detected by NBI only.The sensitivity, specificity, positive and negative predictive values for detection of premalignant lesions were 71, 58,65 and 65% for NBI and 51, 67, 62 and 55% for WLE,respectively.Conclusions NBI increases the diagnostic yield for detection of advanced premalignant gastric lesions compared to routine WLE.
Capelle
Lisette G
LG
Department of Gastroenterology and Hepatology, ErasmusUniversity Medical Center, Room L 462, 3015 CE Rotterdam,The Netherlands. L.Capelle@erasmusmc.nl
Haringsma
Jelle
J
de Vries
Annemarie C
AC
Steyerberg
Ewout W
EW
Biermann
Katharina
K
van Dekken
Herman
H
Kuipers
Ernst J
EJ
D000328:Adult; D000368:Aged; D001706:Biopsy; D005260:Female; D005773:Gastroscopy / Q000379:methods*; D006801:Humans; D008297:Male; D008679:Metaplasia / Q000473:pathology*; D008875:Middle Aged; D011230:Precancerous Conditions / Q000473:pathology*; D011446:Prospective Studies; D013270:Stomach / Q000473:pathology*; D013274:Stomach Neoplasms / Q000473:pathology*
Hepatogastroenterology. 1999 Jan-Feb;46(25):162-6
10228782
Gastrointest Endosc. 2004 Feb;59(2):191-8
14745391
Endoscopy. 2007 Nov;39(11):937-41
18008201
Gastric Cancer. 2008;11(1):15-21; discussion 21-2
18373173
Gastroenterology. 2005 Oct;129(4):1179-86
16230072
Endoscopy. 2005 Dec;37(12):1215-9
16329020
Gastrointest Endosc. 2008 May;67(6):843-53
18440377
Gastrointest Endosc. 2009 Jul;70(1):18-25
19249770
Endoscopy. 2003 Nov;35(11):946-50
14606018
Am J Surg Pathol. 1996 Oct;20(10):1161-81
8827022
Endoscopy. 2002 Oct;34(10):772-7
12244497
Endoscopy. 2006 Aug;38(8):819-24
17001572
J Gastroenterol. 2006 Apr;41(4):332-8
16741612
Heart. 2000 Feb;83(2):236
10744442
Gut. 2002 Jul;51(1):130-1
12077106
Endoscopy. 1984 May;16(3):101-4
6734532
Curr Opin Gastroenterol. 2008 Sep;24(5):631-7
19122507
Gastrointest Endosc. 2010 Jun;71(7):1150-8
20381801
Endoscopy. 2004 Dec;36(12):1080-4
15578298
J Gastroenterol Hepatol. 2000 Oct;15 Suppl:G49-57
11100994
Am J Gastroenterol. 1979 Apr;71(4):376-9
453128
Gastroenterology. 2005 Nov;129(5):1807-8
16285989
Endoscopy. 2004 Feb;36(2):165-9
14765314
Cancer Res. 1992 Dec 15;52(24):6735-40
1458460
Gut. 2005 Apr;54(4):461-8
15753528
Endoscopy. 2009 Apr;41(4):310-5
19340733
Gut. 2003 Jan;52(1):28-33
12477755
Aliment Pharmacol Ther. 2008 Oct 1;28(7):854-67
18637003
Endoscopy. 2007 Mar;39(3):202-7
17273960
Helicobacter. 2007 Feb;12(1):1-15
17241295
Helicobacter. 2010 Aug;15(4):259-64
20633186
Gastroenterology. 2008 Apr;134(4):945-52
18395075